Iovance said it issued a press release updating its full-year 2026 revenue forecast. The filing gives no new sales figure or says whether expected revenue rose or fell, so it does not change the outlook by itself.
Without the revised revenue figure or an explanation of the change, readers cannot tell whether expected sales rose or fell. This filing alone does not change Iovance's business outlook.
Follow Iovance Biotherapeutics, Inc. (IOVA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IOVA